Although stimulation of the IFN signaling inhibited cell proliferation of breast cancer cells (37), chronic inherent activation of the IFN pathway is now recognized as a major trigger for chemotherapy resistance, radiotherapy resistance, tamoxifen resistance, and CDK4/6i resistance in breast cancer cells (11, 38, 39). This evidence concerns the gene IFNA1 and breast carcinoma.